GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

1L Botensilimab + Balstilimab in Stage IV MSS CRC Without Liver Mets…

Nicholas DeVito

Cancer Screening Molecular Tools

Fengting Yan

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu